Navigation Links
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
Date:5/19/2008

EDT on May 20.

Interested investors and others may participate in the InterMune conference call by dialing 888-799-0528 (U.S.) or 706-634-0154 (international), conference ID# 48122233. A replay of the webcast and teleconference will be available approximately three hours after the call.

The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 48122233.

To access a live audio webcast of the conference call, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at http://www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a research and development portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating a new target in hepatology. For additional information about InterMune and its R&D pipeline, please visit http://www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securit
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InterMune Announces Progress on Pirfenidone in IPF
2. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Announces Start of Phase 1b Trial of ITMN-191
5. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
6. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
7. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
8. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
9. GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)
10. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
11. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... MONICA, Calif. , Aug. 28, 2014  In anticipation ... new infographic is being made available for the first time. ... San Diego offers a snapshot of ... industry. Highlighting everything from the latest employment statistics ... has made San Diego such a ...
(Date:8/28/2014)... LAKE CITY , Aug. 28, 2014 /PRNewswire-iReach/ -- ... 2000 by service academy graduates, has published a ... concentrated, three-day Leadership Excellence Course . In September ... Leadership Excellence Course to Albuquerque , ... Tucson . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate ... The Gambia and Mali ... safety trials of potential vaccines aimed at preventing the disease that ... West Africa . Human trials of ... Health (NIH) and GlaxoSmithKline, are to be accelerated with funding from ...
Breaking Medicine Technology:New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7
... ALBUQUERQUE, N.M., Jan. 26, 2011 ... Board: NMXC ), a developer of medical IT ... the healthcare community, announced today the implementation of a software ... its XR-EXpress telemedicine services to other systems. CEO ...
... SAN DIEGO, Jan. 26, 2011 The following statement ... LLP pursuant to an order of the United States ... TES DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKHOWARD LEVINE, Individually ... Plaintiff, , vs. , ATRICURE, INC., et al., , ...
Cached Medicine Technology:Correction: New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services 2Correction: New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services 3Robbins Geller Rudman & Dowd LLP Announces Notice of Hearing to Determine Approval of Proposed Settlement of Class Action 2
(Date:8/29/2014)... August 29, 2014 As a chiropractic ... Fla., understands that there’s a direct connection between the ... hips and back. "Since conventional shoe inserts and orthotics ... solution of my own," he said. , Customizable to ... better support for the foot in order to help ...
(Date:8/29/2014)... (HealthDay News) -- The main strain of a ... and North Africa originated in sub-Saharan Africa, a ... methicillin-resistant Staphylococcus aureus (CA-MRSA) infections, which ... been hospitalized. These infections typically affect the skin ... through touching contaminated objects such as clothing or ...
(Date:8/29/2014)... For the fifth year in a row, ... observing September 26th as Mesothelioma Awareness Day, by attending ... , Members of the community who wish to ... will be providing t-shirts and signs to participating community ... have received attention from Al Roker and ...
(Date:8/29/2014)... PreDiabetes Centers , the country’s leading prediabetes treatment ... shoppers a 20% discount off orders of $100 or more ... living shop, beginning September 1. , Keeping your body ... the chilly fall season. , Autumn’s cooler, cozier weather often ... ditch the healthy salads and opt for creamy soups, hearty ...
(Date:8/29/2014)... Innovations Television, produced by DMG Productions, announced today ... focusing on health and elderly care, slated to air first ... Americans over 65 will nearly double by 2030, expanding from ... for a total of 72 million people. Though many older ... least one chronic condition and use healthcare services more often ...
Breaking Medicine News(10 mins):Health News: European MRSA Originated in Sub-Saharan Africa, Study Finds 2Health News:Organization to Raise Awareness of Mesothelioma on the Today Show 2Health News:PreDiabetes Centers Online Store Launches Fall Savings Event 2Health News:Innovations with Ed Begley, Jr., Seeking Content for Upcoming Series on Health and Elder Care 2
... Jonas in Los Angeles and,Become Part of "Team Jonas" ... To kick off Diabetes Awareness,Month, Bayer Diabetes Care announced ... meet teen pop sensation Nick Jonas of the Jonas,Brothers ... These Grand Prize winners will meet Nick Jonas in ...
... CLEMSON Clemson University researchers developing imaging agents to ... received $180,000 from the Susan G. Komen Breast Cancer ... cancer deaths in American women. , The new method ... resonance imaging) that may help researchers look at different ...
... University of Bristol brings stem cell therapies for heart ... bodies, ability to respond to an internal ,mayday, signal ... medicine. , Dr Nicolle Krnkel and colleagues at the ... DIY rescue and repair mechanisms when blood supply is ...
... kick off American,Diabetes Month this November, the American ... Detroit, along with Eli,Lilly and Company,s national educational ... Diabetes Update, an educational program for people affected ... Saturday, November 1, at the Greater,Grace Temple, 23500 ...
... from the Blue Cross Blue,Shield of Michigan Foundation ... elementary schools to help youngsters learn healthy lifestyle,habits ... University will use a BCBSM Foundation grant to ... and Redner --,part of Lincoln Consolidated Schools -- ...
... 30 Even though many hospitals have not,taken ... surgery,processes, those that do see significant improvements in ... case study recently,published by Kermit Randa of Surgical ... Group, Inc., outlines the benefits realized through the,implementation ...
Cached Medicine News:Health News:Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners 2Health News:Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners 3Health News:Susan G. Komen Breast Cancer Foundation awards grant for imaging-agent research 2Health News:Stem cell therapies for heart disease -- 1 step closer 2Health News:American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes 2Health News:American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes 3Health News:Blue Cross Blue Shield of Michigan Foundation Grant to Eastern Michigan University Will Help Ypsilanti Elementary Schoolchildren Lead Healthier Lives 2Health News:Blue Cross Blue Shield of Michigan Foundation Grant to Eastern Michigan University Will Help Ypsilanti Elementary Schoolchildren Lead Healthier Lives 3Health News:Healthcare Providers Improve Financial, Clinical and Operational Efficiencies Through IT 2
The Perfecta IMC Stems, manufactured from forged cobalt- chrome, are specifically designed for cemented femoral stem arthroplasty....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Simple straight stem design for the low-demand patient....
Dual offset femoral stems, hip stems that provide unique and competitive features....
Medicine Products: